Tapewire

Nasdaq · USD

CRMD

CorMedix Inc.

Export transactions ↓
Tapewire entity
5280
SEC CIK
0001410098
Parsed reports
315

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 03, 2016 Filed Oct 11, 2016 14:37 UTC Amendment
Baluch KhosoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001354488-16-008375 · issuerdirect_section16.xml · derivative · entry 2

Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2026-09-30

F2 · derivative.exercise_date: The option vests on the date the Company?s common stock attains an average closing price over any period of 30 consecutive trading days equal to or greater than 2.75 times the closing price per share on the lesser of 9/23/16 or 10/3/16 (the ?Stock Price Condition"); provided, that if the Stock Price Condition is met prior to 12/31/18 then the option will not vest until 12/31/18. The option will be forfeited (i) if the stock price on 12/31/18 is below the closing price per share on the lesser of 9/23/16 or 10/3/16, or (ii) if the Stock Price Condition is not met by 10/3/2020.

Read SEC document
October 03, 2016 Filed Oct 11, 2016 14:37 UTC Amendment
Baluch KhosoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 1,250,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001354488-16-008375 · issuerdirect_section16.xml · derivative · entry 1

Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Stock · 1,250,000 shares

Expires 2026-09-30

F1 · derivative.exercise_date: The option vests as follows: 25% on 10/3/2017, 25% on 10/3/2018, 25% on 10/3/2019, and 25% on 10/3/2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.